Develops affordable broad-spectrum cancer vaccines and companion diagnostics that prevent and treat individuals at risk or diagnosed by leveraging frameshift neoantigens from RNA-processing errors. Aims to end cancer deaths globally and conducts preventative vaccine trials in dogs.